Study on Structural Modification of Panaxadiol and Its Anti-Gastric Cancer Activity

ABSTRACT: In this study, untargeted metabolomic sequencing was performed to investigate the metabolic alterations induced by protopanaxadiol derivatives in gastric cancer cells. All cellular samples were collected from control and treatment groups to explore differentially expressed metabolites and key metabolic pathways associated with the anti-gastric cancer effects of protopanaxadiol derivatives.

INSTRUMENT(S): Liquid Chromatography MS - negative - reverse-phase, Liquid Chromatography MS - positive - reverse-phase

PROVIDER: MTBLS15239 | MetaboLights | 2026-08-03

REPOSITORIES: MetaboLights